Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
1. 系统已在2025-03-14 11:04:00对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2213-2600(24)00171-1
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260024001711
其他信息:
出版社: Elsevier BV
作者: Jin-Ji Yang; Jianying Zhou; Si-Yang Maggie Liu; Mingjun Li; Zhiye Zhang; Ying Cheng; Yun Fan; Hongming Pan; Baoqing Wang; Gongyan Chen; Ke Wang; Liyan Jiang; Yanping Hu; Jianhua Shi; Xiaorong Dong; Cuimin Ding; Yunpeng Liu; Zhe Liu; Wangjun Liao; Wei Li; Jun Wang; Shanyong Yi; Qiong Zhao; Aimin Zang; Yuan Chen; Jiuwei Cui; Pengfei Luo; Xionghu Shen; Meili Sun; Changli Wang; Yi-Long Wu; Yi-Long Wu; Jin-Ji Yang; Jianying Zhou; Si-Yang Maggie Liu; Mingjun Li; Zhiye Zhang; Ying Cheng; Yun Fan; Hongming Pan; Baoqing Wang; Gongyan Chen; Ke Wang; Liyan Jiang; Yanping Hu; Jianhua Shi; Xiaorong Dong; Cuimin Ding; Yunpeng Liu; Zhe Liu; Wangjun Liao; Wei Li; Jun Wang; Shanyong Yi; Qiong Zhao; Aimin Zang; Yuan Chen; Jiuwei Cui; Pengfei Luo; Xionghu Shen; Meili Sun; Changli Wang; Yongchun Zhou; Zhuli Wu; Xingli Wang; Juan Sun; Jiayan Guo; Yang Zheng; Xiao Xiang; Ai-min Hui
